Search Medical Condition
Please enter condition
Please choose location from dropdown

Myocardial Ischemia Clinical Trials

A listing of Myocardial Ischemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (605) clinical trials

1.1. Antiplatelet therapy after acute myocardial infarction Dual antiplatelet therapy with aspirin, combined with a P2Y12 receptor inhibitor, is a cornerstone of therapy for acute myocardial infarction (AMI). Treatment with clopidogrel in addition to aspirin resulted in a 20% reduction in major adverse cardiovascular events (MACE) when compared with aspirin ...

Phase N/A

TIGRIS is a multinational, multi-centre, observational, prospective, longitudinal cohort study which will include stable CAD patients with a history of MI 1-3 years ago and high risk of developing atherothrombotic events in a real world setting. The follow-up period is 3 years. Patients will undergo clinical assessments and receive standard ...

Phase N/A

The treatment options this study will compare are: (1) Hybrid Coronary Revascularization [HCR] (a combination of surgery and catheter procedures to open up clogged heart arteries) and (2) Percutaneous Coronary Intervention [PCI] (catheter procedures alone to open up clogged heart arteries). There are no new or "experimental" procedures being tested ...

Phase

This is a prospective, randomized one to one (1:1), multi-center trial designed to evaluate vessel preparation with Orbital Atherectomy (OA) compared to conventional balloon angioplasty technique prior to stent implantation for the treatment of severely calcified coronary artery lesions.  

Phase N/A

The primary purpose of this study is to determine whether treatment with the Cobra PzF stent with 14 day Dual Anti-Platelet Therapy (DAPT) has a better safety profile compared to standard FDA approved Drug Eluting Stent plus 6-Month Dual Anti-Platelet Therapy in patients undergoing coronary intervention who also require oral ...

Phase N/A

The objective of the HeartFlow ADVANCE Registry is to evaluate utility, clinical outcomes and resource utilization of FFRCT-guided evaluation in clinically stable, symptomatic patients with coronary artery disease (CAD) in order to further inform patients, health care providers, and other stakeholders about which technologies are most effective and efficient in ...

Phase N/A

The purpose of this study is to evaluate the incremental benefit of Fractional Flow Reserve (FFR) derived from Coronary Computed Tomographic Angiography (CCTA) (CT-FFR) compared to CCTA with or without stress testing, using invasive FFR as the gold standard for patients with obstructive disease (> 30% and < 90% stenosis).  ...

Phase N/A

The purpose of this study is to determine at what blood count patients should be given a transfusion. During this trial we will be assessing red blood cell transfusion strategies that are currently used in clinical practice and important medical events. Red blood cells are a limited and expensive medical ...

Phase

This study will observe the continued performance of the Medtronic Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System in a real-world more-comer population.

Phase N/A

The purpose of this study is to learn which treatment option is better for patients who have multi-vessel coronary artery disease. The treatment options this study will compare are Hybrid Coronary Revascularization (HCR), a combination of surgery and catheter procedures to open clogged heart arteries, and Percutaneous Coronary Intervention (PCI), ...

Phase N/A